Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, PR China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, Guangzhou, 510515, PR China; Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases, Guangzhou 510515, PR China.
Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, PR China.
Phytomedicine. 2024 Dec;135:156231. doi: 10.1016/j.phymed.2024.156231. Epub 2024 Nov 10.
Acute lung injury (ALI) is the main cause of death in clinical respiratory virus infection. Liang-Ge-San (LGS), a famous traditional Chinese formula, has been proved to be effective in treating ALI caused by lipopolysaccharide. However, the effects of LGS on ALI induced by viral infections remain uncertain.
To investigate the effect and mechanism of action of LGS on viral infection-induced ALI.
The inhibitory effects of LGS on virus-induced inflammation in vitro were evaluated by qRT-PCR and ELISA. The protein expression of α7nAChR was examined by Western blotting. α7nAChR was inhibited by the transfection of siRNA or methyllycaconitine citrate (MLA, an α7nAChR inhibitor) to investigate the role of α7nAChR in the anti-inflammatory effect of LGS. Adoptive culture and co-culture systems of macrophages RAW264.7 and alveolar epithelial cells MLE-12 were established to mimic their interaction. Western blotting, immunofluorescence, flow cytometry and transmission electron microscopy were used to examine the effects of LGS on mitophagy inhibition. In vivo, ALI mouse models induced by SARS-CoV-2, H1N1 or Poly(I:C) infection were established to explore the therapeutic effect and mechanism of LGS.
LGS reduced the release of IL-6, TNF-α and IL-1β and increased the expression of α7nAChR in virus-infected RAW264.7 cells. The blockage of α7nAChR counteracted the anti-inflammatory effect of LGS. Moreover, LGS significantly inhibited autophagy in MLE-12 cells induced by Poly(I:C) in adoptive culture and co-culture systems of RAW264.7 and MLE-12 cells, which could be attenuated after the inhibition of α7nAChR in RAW264.7 cells by decreasing the secretion of IL-6, TNF-α and IL-1β. Further study showed that LGS suppressed TNF-α-induced mitochondrial damage and mitophagy by inhibiting the generation of ROS in MLE-12 cells. In vivo, LGS significantly prolonged the survival time, alleviated pathological injury and acute inflammation of ALI mice induced by SARS-CoV-2, H1N1 or Poly(I:C) infection which were associated with the inhibition of α7nAChR-mediated mitophagy.
This study first demonstrates that LGS inhibits virus infection-induced inflammation in RAW246.7 cells by increasing the expression of α7nAChR, thereby inhibiting mitophagy induction in MLE-12 cells to alleviate ALI. This work indicates that LGS may serve as a candidate drug for treating ALI/ARDS caused by viral infection.
急性肺损伤(ALI)是临床呼吸病毒感染导致死亡的主要原因。梁格散(LGS)是一种著名的中药方剂,已被证明对脂多糖引起的 ALI 有治疗作用。然而,LGS 对病毒感染引起的 ALI 的作用尚不确定。
探讨 LGS 对病毒感染诱导的 ALI 的作用及机制。
采用 qRT-PCR 和 ELISA 检测 LGS 对体外病毒诱导炎症的抑制作用。采用 Western blot 检测 α7nAChR 蛋白表达。通过转染 siRNA 或甲基藜芦碱柠檬酸盐(MLA,一种 α7nAChR 抑制剂)抑制 α7nAChR,探讨其在 LGS 抗炎作用中的作用。建立巨噬细胞 RAW264.7 和肺泡上皮细胞 MLE-12 的体外共培养和混合培养体系,模拟它们的相互作用。采用 Western blot、免疫荧光、流式细胞术和透射电镜观察 LGS 对抑制细胞自噬的影响。在 SARS-CoV-2、H1N1 或 Poly(I:C)感染诱导的 ALI 小鼠模型中,探讨 LGS 的治疗作用及机制。
LGS 降低了病毒感染 RAW264.7 细胞后 IL-6、TNF-α和 IL-1β的释放,增加了 α7nAChR 的表达。α7nAChR 的阻断拮抗了 LGS 的抗炎作用。此外,LGS 明显抑制了 Poly(I:C)在体外共培养和混合培养体系中诱导的 MLE-12 细胞自噬,通过降低 RAW264.7 细胞中 IL-6、TNF-α和 IL-1β的分泌,可以减轻 α7nAChR 的抑制作用。进一步研究表明,LGS 通过抑制 MLE-12 细胞中 ROS 的产生,抑制 TNF-α诱导的线粒体损伤和自噬。在体内,LGS 显著延长了 SARS-CoV-2、H1N1 或 Poly(I:C)感染诱导的 ALI 小鼠的存活时间,减轻了病理损伤和急性炎症,这与抑制 α7nAChR 介导的自噬有关。
本研究首次证明,LGS 通过增加 α7nAChR 的表达抑制 RAW246.7 细胞中病毒感染诱导的炎症,从而抑制 MLE-12 细胞中诱导的自噬,从而减轻 ALI。本研究表明,LGS 可能成为治疗病毒感染引起的 ALI/ARDS 的候选药物。